Angong Niuhuang Pills With Different Bovine Bezoar Formulation Sources in the Treatment of AIS

NANot yet recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

May 1, 2026

Study Completion Date

December 1, 2026

Conditions

Acute Ischemic Stroke

Interventions

DRUG

Z11020076

Beijing Tongrentang Angong Niuhuang Pills (3g once daily as a single dose) for 7 consecutive days.

DRUG

Z20063878

Wuhan Jianmin Dapeng Pharmaceutical Co., Ltd. Angong Niuhuang Pills (3g once daily as a single dose) for 7 consecutive days.

Trial Locations (1)

Tongji Hospital, Wuhan

All Listed Sponsors

lead

Tongji Hospital

OTHER

NCT06883110 - Angong Niuhuang Pills With Different Bovine Bezoar Formulation Sources in the Treatment of AIS | Biotech Hunter | Biotech Hunter